Obsidian Therapeutics, Inc. Common Stock (OBX) — Financial Flexibility Index
Obsidian Therapeutics, Inc. Common Stock (OBX) has a Financial Flexibility Index of -0.06x as of March 2026. Free cash flow of $-22.01 Million (operating CF $-22.01 Million minus capex $0.00) represents 0% of total liabilities ($346.33 Million). Also explore net asset growth rate of Obsidian Therapeutics, Inc. Common Stock to track the company's year-over-year net asset growth rate.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Obsidian Therapeutics, Inc. Common Stock Financial Flexibility Index (2024–2025)
Historical Financial Flexibility Index trend for Obsidian Therapeutics, Inc. Common Stock across 2 annual periods. For the full cash flow conversion analysis, see Obsidian Therapeutics, Inc. Common Stock (OBX) cash conversion ratio.
Annual Financial Flexibility Index for Obsidian Therapeutics, Inc. Common Stock (2024–2025)
Year-by-year free cash flow to debt coverage for Obsidian Therapeutics, Inc. Common Stock. Explore Obsidian Therapeutics, Inc. Common Stock debt service capacity to assess how comfortably operating cash covers total debt obligations.
| Year | Flexibility Index | Free Cash Flow (USD) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | -0.25x | $-90.32 Million | $-90.39 Million | $354.62 Million | ▼ -22.9% |
| 2024 | -0.21x | $-74.22 Million | $-75.00 Million | $358.14 Million | — |